IPO Guru
Bajaj
Listed SME

Modern Diagnostic & Research Centre SME IPO Review

Modern Diagnostic & Research Centre SME IPO has been reviewed by 2 analysts, and the overall consensus is Strong Apply — carrying a score of 100. Out of the 2 analysts who have covered this IPO, 2 recommend subscribing — reflecting a broadly positive view from the analyst community.

The issue is priced in the band of ₹₹85 to ₹90 per share, with a minimum application size of 1600 shares. Subscription ran from 31 Dec 2025 to 02 Jan 2026. The issue size is ₹0 crore, entirely a fresh issue. As of now, the grey market premium (GMP) for Modern Diagnostic & Research Centre SME IPO is quoting at ₹14 (16%), which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

Analyst verdict & score

One score out of 100, aggregated from every analyst verdict tracked for this issue. How it's calculated

Sentiment score
100/ 100
Strong Apply 2 of 2 recommend subscribing
How analysts voted
Apply 2

Higher consensus indicates broader analyst agreement.

Detailed review

What the analyst reports say, grouped by the question you're likely asking.

General review

Modern Diagnostic IPO bidding started from Dec 31, 2025 and ended on Jan 2, 2026. The allotment for Modern Diagnostic IPO was finalized on Jan 5, 2026. Modern Diagnostic IPO will list on BSE SME with a tentative listing date fixed as Jan 7, 2026.

How this is written: an AI-assisted summary of the 2 analyst reports listed below. It reports their views; IPO Guru does not make buy or sell recommendations.

Advertisement

Analyst reviews

Ordered by each analyst's track record over the past year; analysts still building one are listed last.

Analyst Verdict Report
Apply PDF
Apply PDF

Latest IPO reviews

How analysts rated the most recent mainboard issues — and, where they have listed, how the call played out.

Frequently asked

Should I apply for Modern Diagnostic & Research Centre SME IPO?

The analyst consensus for Modern Diagnostic & Research Centre SME IPO tracked on this page is Strong Apply, with a score of 100/100. Out of 2 analysts who have reviewed this IPO, 2 recommend subscribing. IPO Guru does not make buy or sell recommendations. Read the individual analyst reports and consult a SEBI-registered advisor before investing.

What does the score of 100 mean for Modern Diagnostic & Research Centre SME IPO?

The score of 100 is an aggregate of all analyst ratings tracked for Modern Diagnostic & Research Centre SME IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Read the individual analyst verdicts above for more context.

What was the actual listing price of Modern Diagnostic & Research Centre SME IPO?

Modern Diagnostic & Research Centre SME IPO listed on January 7, 2026 at ₹90, against the issue price of ₹90 — a gain of +0% (₹0 per share). View the full GMP history page for day-wise pre-listing trends.

What is the price band and lot size of Modern Diagnostic & Research Centre SME IPO?

Modern Diagnostic & Research Centre SME IPO was priced at ₹₹85 to ₹90 per share. The minimum lot size is 1600 shares. Subscription ran from 31 Dec 2025 to 02 Jan 2026.

Explore Modern Diagnostic & Research Centre SME IPO further

Analyst views are one input. Read them alongside the demand, the grey market and the filings before you decide.

Modern Diagnostic & Research Centre SME IPO review

A verdict is an opinion, not a guarantee.

IPO Guru collects analyst views, GMP, subscription and allotment for every Mainboard and SME issue. Weigh them together — and against the offer document — before you apply.

Join the WhatsApp channel Full IPO details

Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.

Consensus
Strong Apply
Score
100 / 100
Listed at
₹90
Full IPO details
Advertisement